U.S. flag

An official website of the United States government

GTR Home > > Psoma Covid-19 RT test

Overview

Test order codeHelp: 5408

Test name

Help

Psoma Covid-19 RT test (Covid-19 test)

Purpose of the test

Help

This is a clinical microbial test intended for Help: Microbe identification

Condition

Help

Click Indication tab for more information.

How to order

Help

Order URL Help: https://psomagen.com/covid-test/

Specimen source

Nasal swab
Specimen requirements: https://psomagen.com/covid-test/

Methodology

Help
Molecular Genetics
RRNA analysis
RT-qPCR
  • Roche LightCycler 480
  • Roche LightCycler 480

Summary of what is tested

Click Methodology tab for more information.

Clinical utility

Help

Not provided

Clinical validity

Help

A clinical study was performed to evaluate the performance of the Psoma COVID-19 RT Test. Results obtained with a total of 110 clinical nasopharyngeal swab samples (55 negatives and 55 positives for SARS-CoV-2) tested with FDA EUA RT-PCR assays (TaqPath COVID-19 Method (EUA200010) and LabCorp COVID-19 RT_PCR Test (EUA200011) were compared to results obtained with the Psoma COVID-19 RT Test.

Citations

Not provided

Testing strategy

Help

The Psoma COVID-19 RT test is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper respiratory specimens (such as nasal, mid-turbinate, nasopharyngeal, and oropharyngeal swab specimens) and bronchoalveolar lavage specimens from individuals suspected of COVID-19 by their healthcare provider. Testing is limited to Psomagen, Inc. certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a to perform high-complexity tests. Results are for the qualitative detection and identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper respiratory specimens (such as nasal, mid-turbinate, nasopharyngeal, and oropharyngeal swab specimens) and broncoalveolar lavage specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infective status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities. 000 The Psoma COVID-19 RT test is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper respiratory specimens (such as nasal, mid-turbinate, nasopharyngeal, and oropharyngeal swab specimens) and bronchoalveolar lavage specimens from individuals suspected of COVID-19 by their healthcare provider. Testing is limited to Psomagen, Inc. certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a to perform high-complexity tests. Results are for the qualitative detection and identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper respiratory specimens (such as nasal, mid-turbinate, nasopharyngeal, and oropharyngeal swab specimens) and broncoalveolar lavage specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infective status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities.

Test services

Help
  • Confirmation of research findings

Clinical resources

Practice guidelines

  • NICE, 2022
    UK NICE Guideline NG191, COVID-19 rapid guideline: managing COVID-19

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.